4SC-203

DB12669InvestigationalSmall molecule

4SC-203 has been used in trials studying the treatment of Acute Myeloid Leukemia.

Mechanism: Pharmacologically active on Receptor-type tyrosine-protein kinase FLT3 and Vascular endothelial growth factor receptor
Curator reviewed
Formula / weight: C₃₃H₃₈N₈O₄S · 642.78 g/mol (avg)
Code names: 4SC-203

Resolves to

Compound

Structure

InChIKeyMAFACRSJGNJHCF-UHFFFAOYSA-NSMILESCOC1=CC=C(C)C=C1NC(=O)NC1=NC2=CC=C(NC3=NC=NC4=CC(OCCCN5CCN(C)CC5)=C(OC)C=C34)C=C2S1

Targets

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with 4SC-203, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.